Ablation Confirmation Study



Status:Not yet recruiting
Conditions:Liver Cancer, Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:3/13/2019
Start Date:September 30, 2019
End Date:December 31, 2022
Contact:Bertha Fearon
Email:bfearon1@its.jnj.com
Phone:908-524-3749

Use our guide to learn which trials are right for you!

A Multicenter Study to Evaluate NEUWAVE Microwave Ablation System Using Ablation Confirmation in Patients With a Soft Tissue Liver Lesion

Prospective, single-arm, multicenter study that will generate clinical data using the NEUWAVE
MicroWave Ablation System with AC (Ablation Confirmation) software in patients undergoing
ablation of a soft tissue liver lesion.

Prospective, single-arm, multicenter study that will generate clinical data on 100 adult
patients using the NEUWAVE MicroWave Ablation System with AC (Ablation Confirmation) software
in patients undergoing ablation of a soft tissue liver lesion. AC software is a computed
tomography (CT) image processing software package available as an optional feature for use
with the NEUWAVE Microwave Ablation System. AC imports images from CT scanners for display
and processing during ablation procedures to assist physicians in identifying ablation
targets, assessing optimal ablation probe placement, and confirming the adequacy of the
ablation margin.

All ablations will be performed percutaneously by an interventional radiologist while the
patient is under general anesthesia or deep conscious sedation.

Inclusion Criteria:

1. A patient with one liver lesion less than or equal to 5cm undergoing microwave
ablation using the NEUWAVE Microwave Ablation System

2. Intent to use Ablation Confirmation during the procedure

3. Written Informed Consent to voluntarily participate in the study, follow CT scan
schedule, and authorize the transfer of his/her data to the Sponsor

4. Patients greater than or equal to 18 years of age

5. Performance status 0-2 (Eastern Cooperative Oncology Group [ECOG]) classification

6. Functional hepatic reserve based on the Child-Pugh score (Class A or B)

7. Lesion must be visualized by non-contrast enhanced CT scan or the patient must
tolerate contrast and meet institutional guidelines for contrast use based on
glomerular filtration rate (GFR)

Exclusion Criteria:

1. Active bacterial infection or fungal infection on the day of the ablation

2. Patients with implantable pacemakers or other electronic implants

3. Platelet count less than 50,000/mm cubed

4. Patients with uncorrectable coagulopathy at the time of ablation

5. Currently breastfeeding or pregnant (latter confirmed by serum pregnancy test)

6. Physical or psychological condition which would impair study participation

7. ASA (American Society of Anesthesiologists) score of great or equal to 4

8. Cannot safely obtain a 1cm margin

9. Planned use of hydrodissection

10. Systemic administration (intravenous or oral) of steroids, including herbal
supplements, that contain steroids, within 30 days prior to the study ablation
procedure

11. Chemotherapy or radiation therapy, within 30 days prior to the study ablation
procedure

12. INR greater than 1.5
We found this trial at
6
sites
Houston, Texas 77030
Principal Investigator: Bruno Odisio
?
mi
from
Houston, TX
Click here to add this to my saved trials
8700 Beverly Blvd # 8211
Los Angeles, California 90048
(1-800-233-2771)
Principal Investigator: Ashley Wachsman
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Frankfurt,
Principal Investigator: Thomas Vogel, MD
?
mi
from
Frankfurt,
Click here to add this to my saved trials
Madison, Wisconsin 53792
(608) 263-2400
Principal Investigator: Timothy Ziemlewicz
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
?
mi
from
Madison, WI
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Constantinos Sofocleous
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Matthew Callstrom
?
mi
from
Rochester, MN
Click here to add this to my saved trials